|Title:||Deciphering tacrolimus-induced toxicity in pancreatic β cells||Authors:||Trinanes, J.
Rodriguez-Rodriguez, A. E.
Brito Casillas, Yeray
De Vries, A. P. J.
Salido Ruíz, Eduardo
|UNESCO Clasification:||32 Ciencias médicas||Keywords:||Composite Tissue Allotransplantation
Ovarian-Function, et al
|Issue Date:||2017||Journal:||American Journal of Transplantation||Abstract:||β Cell transcription factors such as forkhead box protein O1 (FoxO1), v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA), pancreatic and duodenal homeobox 1, and neuronal differentiation 1, are dysfunctional in type 2 diabetes mellitus (T2DM). Posttransplant diabetes mellitus resembles T2DM and reflects interaction between pretransplant insulin resistance and immunosuppressants, mainly calcineurin inhibitors (CNIs). We evaluated the effect of tacrolimus (TAC), cyclosporine A (CsA), and metabolic stressors (glucose plus palmitate) on insulinoma β cells in vitro and in pancreata of obese and lean Zucker rats. Cells were cultured for 5 days with 100 μM palmitate and 22 mM glucose; CsA (250 ng/mL) or TAC (15 ng/mL) were added in the last 48 h. Glucose plus palmitate increased nuclear FoxO1 and decreased nuclear MafA. TAC in addition to glucose plus palmitate magnified these changes in nuclear factors, whereas CsA did not. In addition to glucose plus palmitate, both drugs reduced insulin content, and TAC also affected insulin secretion. TAC withdrawal or conversion to CsA restored these changes. Similar results were observed in pancreata of obese animals on CNIs. TAC and CsA, in addition to glucose plus palmitate, induced comparable inhibition of calcineurin and nuclear factor of activated T cells (NFAT); therefore, TAC potentiates glucolipotoxicity in β cells, possibly by sharing common pathways of β cell dysfunction. TAC-induced β cell dysfunction is potentially reversible. Inhibition of the calcineurin–NFAT pathway may contribute to the diabetogenic effect of CNIs but does not explain the stronger effect of TAC compared with CsA.||URI:||http://hdl.handle.net/10553/35425||ISSN:||1600-6135||DOI:||10.1111/ajt.14323||Source:||American Journal of Transplantation [ISSN 1600-6135], v. 17 (11), p. 2829-2840|
|Appears in Collections:||Artículos|
checked on Oct 2, 2022
WEB OF SCIENCETM
checked on Oct 2, 2022
checked on Sep 10, 2022
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.